4 hours Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Consensus Recommendation of “Moderate Buy” by Brokerages MarketBeat
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the eight brokerages that are covering the company, MarketBeat Ratings reports. One equities research analyst has rate…